← Eichor
Condition: Active Ulcerative Colitis Uc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Active Ulcerative Colitis Uc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Phase 2 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07507513Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Phase N/A · 38 location(s) · Pfizer · NCT06294925Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopea
Phase N/A · 1 location(s) · Imelda GI Clinical Research Center · NCT07621783A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Phase 1/Phase 2 · 1 location(s) · Mage Biologics · NCT07374471Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
NA · 1 location(s) · Biao Zou · NCT05679622Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Phase 2 · 1 location(s) · Medical University of Lodz · NCT06453317A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagno
NA · 6 location(s) · All India Institute of Medical Sciences · NCT06895252A Study for HSK47388 in Participants With Ulcerative Colitis
Phase 2 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07335055Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcer
Phase N/A · 56 location(s) · AbbVie · NCT06764706Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Phase 1/Phase 2 · 90 location(s) · Xencor, Inc. · NCT06619990A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase 2 · 66 location(s) · Mirador Therapeutics, Inc. · NCT07113522A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · 49 location(s) · Takeda · NCT06095128A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative C
NA · 6 location(s) · All India Institute of Medical Sciences · NCT06906445Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Modera
Phase 2 · 20 location(s) · Biocad · NCT07080034Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Phase 2 · 1 location(s) · Northwestern University · NCT07427017LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · 258 location(s) · Eli Lilly and Company · NCT07415044Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Coliti
Phase 2 · 32 location(s) · Odyssey Therapeutics · NCT06850727IBD Biomarker Discovery and Validation Platform
Phase N/A · 2 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07686406A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Seve
Phase 2 · 103 location(s) · Genentech, Inc. · NCT06979336Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Phase 2 · 28 location(s) · InSilico Medicine Hong Kong Limited · NCT07265570An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate
Phase N/A · 3 location(s) · AbbVie · NCT06838845Early Inflammatory Bowel Disease Progression
Phase N/A · 1 location(s) · Pontificia Universidad Catolica de Chile · NCT06756100Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsi
Phase N/A · 1 location(s) · IRCCS Policlinico S. Donato · NCT07710287AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis
NA · 1 location(s) · ENBIOSIS BIOTECHNOLOGIES · NCT07619638A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Phase 2 · 16 location(s) · Takeda · NCT06764615Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
Phase 1 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT05786404A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT06073873AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
Phase N/A · 11 location(s) · University College Cork · NCT06709209A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
Phase 1/Phase 2 · 15 location(s) · Innatus Therapeutics (Shanghai) Co., Ltd. · NCT07692165
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.